| Women |
10 906 (50.6) |
| Age (years) |
64.8±11.9 |
| (min–max) |
(16–100) |
| Body mass index (kg m−2) (n=14 722) |
24.31±3.71 |
| Alcohol drinkers |
3474 (16.1) |
| Current smokers |
2652 (12.3) |
| Previous antihypertensive treatment |
10 834 (50.2) |
| |
|
| History |
| Cerebro- or cardiovascular disease |
2262 (10.5) |
| Cerebrovascular disease |
1430 (6.6) |
| Cardiovascular disease |
975 (4.5) |
| |
|
| Complications |
| Dyslipidemia |
9592 (44.5) |
| Diabetes mellitus |
4409 (20.4) |
| Cardiac disease |
2004 (9.3) |
| Renal disease |
1474 (6.8) |
| Hepatic disease |
1429 (6.6) |
| |
|
| Main concomitant drugs |
| Antidyslipidemic drug |
5872 (27.2) |
| Antidiabetic drug |
2956 (13.7) |
| Anticoagulant or antiplatelet drug |
2596 (12.0) |
| |
|
| Lipid |
| Total cholesterol (mg dl−1) |
202.6±36.0 |
| Low-density lipoprotein cholesterol (mg dl−1) |
118.8±31.0 |
| High-density lipoprotein cholesterol (mg dl−1) |
58.5±15.7 |
| Triglycerides (mg dl−1) |
133.4±86.3 |
| Fasting plasma glucose (mg dl−1) |
106.0±29.8 |
| Hemoglobin A1c (NGSP) (%) |
6.20±1.08 |
| Creatinine (mg dl−1) |
0.79±0.32 |
| Estimated glomerular filtration rate (ml min−1 per 1.73m2) |
72.4±20.2 |
